Research article · 2015
Research articlePublished 17 Aug 2021
Evaluating the Immunity to Tetanus in Adults with the Enzyme-Linked Immunosorbent Assay
1Department of Infectious Diseases, Katip Celebi University, Izmir, Turkey; 2Department of Infectious Diseases, Dokuz Eylul University, Izmir, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Tetanus is a worldwide preventable disease with vaccination having an incidence of approximately one million, which causes mortality especially in neonates in developing countries and in individuals over 60 years old in developed countries. The disease particularly affects unvaccinated people or those with an incomplete vaccination schedule. It has been reported in literature that immunity to tetanus diminishes with increased age. The aim of this study was to determine the immunity to tetanus and the need for booster immunization in the adult population in Turkey. Methods and findings: A total of 339 blood samples were collected from patients aged between 20-81 years. Tetanus antitoxin levels were studied with the Enzyme Linked Imumunosorbent Assay (ELISA) method (Genzyme Virotech Germany). Titers <0.1 IU/ml were considered to show insufficient immunity to tetanus. Of the studied population, 39.5% had insufficient immunity against tetanus. With increasing age, tetanus immunity was seen to decrease. The immunity to tetanus was seen to be higher in patients who had received a booster immunization in the past 5 years compared with the groups with a last booster immunization 5-10 years previously or more than 10 years ago. A higher rate was also determined in the female population with a pregnancy history in the last 5 years compared with the groups with pregnancy 5-10 years previously or more than 10 years ago. Conclusion: Booster doses for adults are needed. The present vaccination schedule must include boosters every 10 years in order to provide immunity against tetanus for all the population.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2018
Evaluation of a Commercial Enzyme-Linked Immunosorbent Assay Kit for Detection of IgM Antibody against Leptospira in Human Sera for Patients admitted in Malaysian Hospitals
Conference abstract · 1 Sep 2015
Uremic effect on immunofluorescence and enzyme-linked immunosorbent assays for detection of human herpes virus type 8 antibodies
Conference abstract
Detection of Capillaria philippinensis coproantigen in clinical cases of capillariasis by enzyme-linked immunosorbent assay using polyclonal antibodies
Opinion · 28 Jun 2023
Probing the Immune System: Exploring Enzyme-Linked Immunosorbent Assays (ELISA)
More from this journal
The newest in Journal of Infectious Diseases & Therapy.
Research article · 14 Apr 2026
Ethiopian Child Immunization Coverage Prevalence and Determinants: Evidence from the 2019 Mini-Demographic and Health Survey
Research article · 5 May 2025
The Ultimate Cure for the COVID Syndemic
Mini review · 29 Apr 2025
COVID-19 Systematic Mini-Review as of April 2025
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Therapy
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Banu Karaca”
- BylineArticles whose byline prints “Nur Yapar”
- BylineArticles whose byline prints “Ayse Yuce”